TOR3A
Torsin-3A
Also known as: ADIR, ADIR2, FLJ22345, TOR3A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H497
- Gene
- TOR3A
- Ensembl
- ENSG00000186283
- Chromosome
- 1
- Canonical length
- 397 aa
- Protein class
- Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
Enables ATP hydrolysis activity. Located in endoplasmic reticulum lumen. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
397 residues, UniProt reviewed canonical sequence.
>Q9H497|TOR3A
1 MLRGPWRQLW LFFLLLLPGA PEPRGASRPW EGTDEPGSAW AWPGFQRLQE QLRAAGALSK
61 RYWTLFSCQV WPDDCDEDEE AATGPLGWRL PLLGQRYLDL LTTWYCSFKD CCPRGDCRIS
121 NNFTGLEWDL NVRLHGQHLV QQLVLRTVRG YLETPQPEKA LALSFHGWSG TGKNFVARML
181 VENLYRDGLM SDCVRMFIAT FHFPHPKYVD LYKEQLMSQI RETQQLCHQT LFIFDEAEKL
241 HPGLLEVLGP HLERRAPEGH RAESPWTIFL FLSNLRGDII NEVVLKLLKA GWSREEITME
301 HLEPHLQAEI VETIDNGFGH SRLVKENLID YFIPFLPLEY RHVRLCARDA FLSQELLYKE
361 ETLDEIAQMM VYVPKEEQLF SSQGCKSISQ RINYFLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TOR3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- spleen: 48 nTPM
- lymph node: 43 nTPM
- tonsil: 42 nTPM
- bone marrow: 38 nTPM
- skeletal muscle: 31 nTPM
- liver: 31 nTPM
Single-cell type
- plasma cells: 169 nCPM
- oocytes: 161 nCPM
- cdc: 84 nCPM
- extravillous trophoblasts: 72 nCPM
- hofbauer cells: 66 nCPM
- pdcs: 64 nCPM
Immune cell
- memory B-cell: 98 nTPM
- plasmacytoid DC: 93 nTPM
- myeloid DC: 86 nTPM
- naive B-cell: 74 nTPM
- classical monocyte: 71 nTPM
- non-classical monocyte: 60 nTPM
Brain region
- hypothalamus: 25 nTPM
- white matter: 24 nTPM
- choroid plexus: 24 nTPM
- medulla oblongata: 22 nTPM
- spinal cord: 20 nTPM
- basal ganglia: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TOR3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TOR3A as an antibody target. Whether an autoantibody or antibody against TOR3A could matter depends on whether native TOR3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TOR3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TOR3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...